HCW Biologics (NASDAQ:HCWB) reported quarterly losses of $(1.02) per share. This is a 68.03 percent increase over losses of $(3.19) per share from the same period last year. The company reported $27.010 thousand in sales this quarter. This is a 93.16 percent decrease over sales of $394.804 thousand the same period last year.